Intravenous Infusion Pumps Market Report 2026

Intravenous Infusion Pumps Market Overview

• Intravenous Infusion Pumps market size has reached to $6.37 billion in 2025 • Expected to grow to $9.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Prevalence Of Bleeding Disorders Driving Market Growth Due To Increased Demand For Precision Drug Delivery Systems • Market Trend: Embedding Smart?Accurate™ Technology for Real?Time Flow Stability and Medication Safety • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Intravenous Infusion Pumps Market?

Intravenous infusion pumps are devices designed to administer fluids, medications, or nutrients directly into a patient's veins with accuracy and consistency, supporting effective treatment in critical and routine medical care. The intravenous infusion pumps market covered in this report is segmented by product into the volumetric, syringe, enteral, ambulatory, IV disposables, and others. A syringe is a reciprocating pump used to deliver drugs and consists of a plunger. It is also segmented by application into chemotherapy, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology, others, and by end-user into hospitals, ambulatory surgical centers, cancer treatment centers, specialty clinics, and others.

What Is The Intravenous Infusion Pumps Market Growth Forecast?

The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $9.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for interoperable infusion devices, rising focus on patient-centric care models, expansion of remote patient monitoring, growing investments in smart healthcare infrastructure, increasing adoption of home-based infusion therapies. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising use of dose error reduction software, growing integration of connected hospital systems, expansion of ambulatory and home infusion therapies, enhanced focus on medication safety.

Global Intravenous Infusion Pumps Market Segmentation

1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products 2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users Subsegments: 1) By Volumetric: Large-volume Pumps, Small-volume Pumps 2) By Syringe: Micro Syringe Pumps, Macro Syringe Pumps 3) By Enteral: Portable Enteral Pumps, Stationary Enteral Pumps 4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps, Insulin Pumps, Disposable Pumps 5) By IV Disposables: IV Tubing Sets, IV Catheters, IV Cannulas, IV Solutions 6) By Other Products: Implantable Pumps, Smart Pumps, Elastomeric Pumps

What Is The Driver Of The Intravenous Infusion Pumps Market?

The increasing prevalence of bleeding disorders is expected to propel the growth of the intravenous infusion pump market. Bleeding disorders are a category of medical illnesses that impair the body's capacity to correctly produce blood clots. The rising prevalence of bleeding disorders is due to genetic factors and increased consanguineous marriages, which elevate the chances of inherited clotting deficiencies in populations. Intravenous infusion pumps are a significant therapy tool for bleeding problems as they are used to deliver these drugs in a precise and regulated way, guaranteeing the patient receives the exact dose at the correct time. For instance, in April 2025, according to Pfizer, a US-based biopharmaceutical company, more than 11,800 people were living with haemophilia A or B in the United Kingdom in 2023 to 2024, while the condition impacts over 800,000 people worldwide and is mostly diagnosed in early childhood. Therefore, the increasing prevalence of bleeding disorders is driving the growth of the intravenous infusion pump industry going forward.

Key Players In The Global Intravenous Infusion Pumps Market

Major companies operating in the intravenous infusion pumps market are B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation

Global Intravenous Infusion Pumps Market Trends and Insights

Major companies operating in the intravenous infusion pumps market are focusing on technological innovation, such as real‑time flow monitoring systems to detect and correct infusion rate deviations dynamically, improving accuracy and patient safety. Real-time flow monitoring systems refer to advanced medical devices that continuously measure and track the flow rate of fluids, such as medication or blood, in real time to ensure accurate and timely delivery during treatment. For instance, in February 2023, Mindray, a China-based manufacturer of high-tech medical devices, launched its BeneFusion I‑/U Series infusion systems, which incorporate Smart Accurate™ technology that continuously monitors the actual drug flow rate and provides real‑time feedback to correct deviations. The pumps also offer sleek, intuitive UIs with full-touch screens, a customizable drug library, and a patented BolusGUARD motorized syringe loading system to prevent unintentional boluses during loading. In addition, they support connectivity via Mindray’s M-IoT system for centralized device management, maintenance analytics, and drug library updates — reinforcing safety and efficiency across hospital networks.

What Are Latest Mergers And Acquisitions In The Intravenous Infusion Pumps Market?

In May 2025, Boston Scientific, a US-basedmedical device company, acquired Intera Oncology, Inc. for approximately $172 million. With this acquisition, Boston Scientific aim is to strengthen its interventional oncology offerings by integrating Intera Oncology’s constant‑flow Intera 3000 Hepatic Artery Infusion Pump and floxuridine chemotherapy drug, used together to deliver targeted hepatic artery infusion (HAI) therapy for liver tumors. Intera Oncology, Inc. is a US-based provider of implantable infusion pumps and chemotherapy drug delivery systems, with a strong track record in hepatic artery infusion therapy.

Regional Outlook

North America was the largest region in the intravenous infusion pumps market in 2025. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intravenous Infusion Pumps Market?

The intravenous infusion pumps market consists of sales of volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.